Witte Kaya E, Hertel Oliver, Windmöller Beatrice A, Helweg Laureen P, Höving Anna L, Knabbe Cornelius, Busche Tobias, Greiner Johannes F W, Kalinowski Jörn, Noll Thomas, Mertzlufft Fritz, Beshay Morris, Pfitzenmaier Jesco, Kaltschmidt Barbara, Kaltschmidt Christian, Banz-Jansen Constanze, Simon Matthias
Department of Cell Biology, Faculty of Biology, University of Bielefeld, Universitätsstrasse 25, 33699 Bielefeld, Germany.
Forschungsverbund BioMedizin Bielefeld, OWL (FBMB e.V.), Maraweg 21, 33699 Bielefeld, Germany.
Cancers (Basel). 2021 Mar 6;13(5):1136. doi: 10.3390/cancers13051136.
Cancer stem cells (CSCs) are crucial mediators of tumor growth, metastasis, therapy resistance, and recurrence in a broad variety of human cancers. Although their biology is increasingly investigated within the distinct types of cancer, direct comparisons of CSCs from different tumor types allowing comprehensive mechanistic insights are rarely assessed. In the present study, we isolated CSCs from endometrioid carcinomas, glioblastoma multiforme as well as adenocarcinomas of lung and prostate and assessed their global transcriptomes using full-length cDNA nanopore sequencing. Despite the expression of common CSC markers, principal component analysis showed a distinct separation of the CSC populations into three clusters independent of the specific type of tumor. However, GO-term and KEGG pathway enrichment analysis revealed upregulated genes related to ribosomal biosynthesis, the mitochondrion, oxidative phosphorylation, and glycolytic pathways, as well as the proteasome, suggesting a great extent of metabolic flexibility in CSCs. Interestingly, the GO term "NF-kB binding" was likewise found to be elevated in all investigated CSC populations. In summary, we here provide evidence for high global transcriptional similarities between CSCs from various tumors, which particularly share upregulated gene expression associated with mitochondrial and ribosomal activity. Our findings may build the basis for identifying novel therapeutic strategies targeting CSCs.
癌症干细胞(CSCs)是多种人类癌症中肿瘤生长、转移、治疗抵抗和复发的关键介质。尽管它们的生物学特性在不同类型的癌症中得到了越来越多的研究,但很少评估来自不同肿瘤类型的CSCs之间的直接比较,以获得全面的机制性见解。在本研究中,我们从子宫内膜样癌、多形性胶质母细胞瘤以及肺癌和前列腺癌中分离出CSCs,并使用全长cDNA纳米孔测序评估它们的整体转录组。尽管存在常见的CSC标志物表达,但主成分分析显示CSC群体明显分为三个簇,与肿瘤的具体类型无关。然而,基因本体(GO)术语和京都基因与基因组百科全书(KEGG)通路富集分析显示,与核糖体生物合成、线粒体、氧化磷酸化和糖酵解途径以及蛋白酶体相关的基因上调,这表明CSCs具有很大程度的代谢灵活性。有趣的是,在所有研究的CSC群体中,“NF-κB结合”的GO术语同样升高。总之,我们在此提供证据表明,来自各种肿瘤的CSCs之间存在高度的整体转录相似性,特别是共享与线粒体和核糖体活性相关的上调基因表达。我们的发现可能为识别针对CSCs的新型治疗策略奠定基础。